In Sweden, the research & development by business enterprise, pharmaceutical industry in local currency currently stands at 9,845.47 million, reflecting an increase of 1,544.57 million (18.6%) compared to 2020.
Research & development by business enterprise, pharmaceutical industry in local currency in Sweden
No matching regions
Similar regions to Sweden
Business R&D pharmaceutical in local currency
More indicators for Sweden
Government R&D in security as % of government support
2.1%
-0.33%
(2021)
Higher-education-finacing R&D financed by general university in local currency
181,501.95M
+16,181.95M
(2021)
R&D financed by rest of the world in local currency
218,622.84M
+67,392.84M
(2021)
Government R&D financed by rest of the world in local currency
1,858.26M
-1,101.74M
(2021)
Business R&D financed by rest of the world in local currency
185,804.74M
+67,514.74M
(2021)
Non-profit R&D growth rate
-0.36%
-1.64%
(2022)
Sweden Business R&D pharmaceutical in local currency between 2007 and 2021
| Period | Business R&D pharmaceutical in local currency | Change |
|---|---|---|
| 2021 | 9,845.47M | +1,544.57M |
| 2020 | 8,300.90M | +1,318.18M |
| 2019 | 6,982.72M | -89.59M |
| 2018 | 7,072.31M | -465.24M |
| 2017 | 7,537.55M | +232.67M |
| 2016 | 7,304.87M | -278.87M |
| 2015 | 7,583.74M | +930.17M |
| 2014 | 6,653.57M | -306.43M |
| 2013 | 6,960.00M | -218.23M |
| 2012 | 7,178.23M | -571.77M |
| 2011 | 7,750.00M | +1,012.13M |
| 2010 | 6,737.87M | +417.87M |
| 2009 | 6,320.00M | -1,870.98M |
| 2008 | 8,190.98M | -329.02M |
| 2007 | 8,520.00M |